Hansa Biopharma AB (HNSA) — Net Asset Quality Index
Hansa Biopharma AB (HNSA) has a Net Asset Quality Index of -52.7% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Skr837.27 Million minus total liabilities of Skr1.28 Billion yields net assets of Skr-441.06 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read total liabilities of Hansa Biopharma AB for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Hansa Biopharma AB Net Asset Quality Index Over Time (2008–2024)
This chart shows how Hansa Biopharma AB's Net Asset Quality Index has evolved across 17 annual periods from 2008 to 2024. As of June 2025, the index stands at -52.7%, representing net assets of Skr-441.06 Million against total assets of Skr837.27 Million SEK. For live market cap and overall valuation, see Hansa Biopharma AB stock valuation.
Annual Net Asset Quality Index for Hansa Biopharma AB (2008–2024)
The table below presents the year-by-year Net Asset Quality Index for Hansa Biopharma AB from 2008 to 2024, covering 17 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check strategic asset allocation of Hansa Biopharma AB to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (SEK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | -73.7% | Skr-589.83 Million | Skr800.64 Million | Skr1.39 Billion | ▼ -57.2 pp |
| 2023 | -16.5% | Skr-167.88 Million | Skr1.02 Billion | Skr1.19 Billion | ▼ -52.2 pp |
| 2022 | 35.7% | Skr602.91 Million | Skr1.69 Billion | Skr1.08 Billion | ▼ -39.1 pp |
| 2021 | 74.8% | Skr757.57 Million | Skr1.01 Billion | Skr255.24 Million | ▼ -11.8 pp |
| 2020 | 86.6% | Skr1.24 Billion | Skr1.43 Billion | Skr192.37 Million | ▲ +1.9 pp |
| 2019 | 84.7% | Skr562.82 Million | Skr664.24 Million | Skr101.42 Million | ▼ -6.3 pp |
| 2018 | 91.0% | Skr859.88 Million | Skr944.82 Million | Skr84.94 Million | ▼ -1.7 pp |
| 2017 | 92.7% | Skr630.66 Million | Skr680.41 Million | Skr49.75 Million | ▲ +1.4 pp |
| 2016 | 91.3% | Skr283.69 Million | Skr310.67 Million | Skr26.98 Million | ▼ -3.1 pp |
| 2015 | 94.4% | Skr211.53 Million | Skr224.09 Million | Skr12.56 Million | ▲ +2.7 pp |
| 2014 | 91.7% | Skr49.80 Million | Skr54.31 Million | Skr4.51 Million | ▲ +1.7 pp |
| 2013 | 90.0% | Skr45.68 Million | Skr50.78 Million | Skr5.10 Million | ▼ -6.2 pp |
| 2012 | 96.1% | Skr63.24 Million | Skr65.80 Million | Skr2.56 Million | ▲ +11.2 pp |
| 2011 | 84.9% | Skr34.71 Million | Skr40.90 Million | Skr6.19 Million | ▼ -0.2 pp |
| 2010 | 85.1% | Skr32.17 Million | Skr37.80 Million | Skr5.64 Million | ▲ +19.8 pp |
| 2009 | 65.3% | Skr24.92 Million | Skr38.15 Million | Skr13.23 Million | ▼ -25.5 pp |
| 2008 | 90.8% | Skr40.73 Million | Skr44.87 Million | Skr4.13 Million | — |